These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38411724)

  • 1. Effectiveness of prehabilitation during neoadjuvant therapy for patients with esophageal or gastroesophageal junction cancer: a systematic review.
    Ikeda T; Toyama S; Harada T; Noma K; Hamada M; Kitagawa T
    Esophagus; 2024 Jul; 21(3):283-297. PubMed ID: 38411724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nutrition-based prehabilitation on the postoperative outcomes of patients with esophagogastric cancer undergoing surgery: A systematic review and meta-analysis.
    Shen Y; Cong Z; Ge Q; Huang H; Wei W; Wang C; Jiang Z; Wu Y
    Cancer Med; 2024 Jul; 13(14):e70023. PubMed ID: 39001679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prehabilitation exercise therapy before elective abdominal aortic aneurysm repair.
    Fenton C; Tan AR; Abaraogu UO; McCaslin JE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013662. PubMed ID: 34236703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehabilitation for patients undergoing neoadjuvant therapy prior to cancer resection: a systematic review and meta-analysis.
    Chen Y; Sebio-García R; Iglesias-Garcia E; Reguart N; Martinez-Palli G; Bello I
    Support Care Cancer; 2024 Oct; 32(11):749. PubMed ID: 39466349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials.
    Zhao X; Ren Y; Hu Y; Cui N; Wang X; Cui Y
    PLoS One; 2018; 13(8):e0202185. PubMed ID: 30138325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neoadjuvant immunotherapy in resectable gastric/gastroesophageal junction tumors: a meta-analysis and systematic review.
    Wang J; Tong T; Zhang G; Jin C; Guo H; Liu X; Zhang Z; Li J; Zhao Y
    Front Immunol; 2024; 15():1339757. PubMed ID: 38352873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
    Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Jensen K;
    Cochrane Database Syst Rev; 2013 May; (5):CD008107. PubMed ID: 23728671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal Prehabilitation During Neoadjuvant Therapy Prior to Esophagogastric Cancer Resection: Effect on Cardiopulmonary Exercise Test Performance, Muscle Mass and Quality of Life-A Pilot Randomized Clinical Trial.
    Allen SK; Brown V; White D; King D; Hunt J; Wainwright J; Emery A; Hodge E; Kehinde A; Prabhu P; Rockall TA; Preston SR; Sultan J
    Ann Surg Oncol; 2022 Mar; 29(3):1839-1850. PubMed ID: 34725764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does prehabilitation before esophagectomy improve postoperative outcomes? A systematic review and meta-analysis.
    An KR; Seijas V; Xu MS; Grüßer L; Humar S; Moreno AA; Turk M; Kasanagottu K; Alzghari T; Dimagli A; Ko MA; Villena-Vargas J; Papatheodorou S; Gaudino MFL
    Dis Esophagus; 2024 Feb; 37(3):. PubMed ID: 38018252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility, tolerability, and effects of exercise-based prehabilitation after neoadjuvant therapy in esophagogastric cancer patients undergoing surgery: an interventional pilot study.
    Argudo N; Rodó-Pin A; Martínez-Llorens J; Marco E; Visa L; Messaggi-Sartor M; Balañá-Corberó A; Ramón JM; Rodríguez-Chiaradía DA; Grande L; Pera M
    Dis Esophagus; 2021 Apr; 34(4):. PubMed ID: 32940327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of unimodal or multimodal prehabilitation on patients undergoing surgery for esophagogastric cancer: a systematic review and meta-analysis.
    Zhao B; Zhang T; Chen Y; Zhang C
    Support Care Cancer; 2023 Dec; 32(1):15. PubMed ID: 38060053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.
    Janmaat VT; Steyerberg EW; van der Gaast A; Mathijssen RH; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD004063. PubMed ID: 29182797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the acceptability of and adherence to prehabilitation and rehabilitation in patients undergoing major abdominal surgery: A systematic review and meta-analysis.
    Alsuwaylihi A; Skořepa P; Prado CM; Gomez D; Lobo DN; O'Connor D
    Clin Nutr ESPEN; 2024 Oct; 63():709-726. PubMed ID: 39142632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a pre- and post-operative exercise program versus standard care on physical activity and sedentary behavior of patients with esophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (the PERIOP-OG Trial): a randomized controlled trial†.
    Loughney L; Murphy K; Tully R; Robb WB; McCaffrey N; Dowd K; Skelly F
    Dis Esophagus; 2024 Oct; 37(10):. PubMed ID: 38769843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prehabilitation in Patients With Breast Cancer Receiving Neoadjuvant Therapy to Minimize Musculoskeletal Postoperative Complications and Enhance Recovery (PREOPtimize): A Protocol for a Randomized Controlled Trial.
    Casanovas-Álvarez A; Sebio-Garcia R; Ciendones M; Cuartero J; Estanyol B; Padrós J; García-Valdecasas B; Barnadas A; Masia J
    Phys Ther; 2023 Sep; 103(9):. PubMed ID: 37318267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials.
    Steffens D; Nott F; Koh C; Jiang W; Hirst N; Cole R; Karunaratne S; West MA; Jack S; Solomon MJ
    Ann Surg Oncol; 2024 Nov; 31(12):7822-7849. PubMed ID: 38914837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery: study protocol.
    Allen S; Brown V; Prabhu P; Scott M; Rockall T; Preston S; Sultan J
    BMJ Open; 2018 Dec; 8(12):e023190. PubMed ID: 30580268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery.
    Molenaar CJ; van Rooijen SJ; Fokkenrood HJ; Roumen RM; Janssen L; Slooter GD
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013259. PubMed ID: 35588252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a pre- and post-operative exercise programme versus standard care on physical fitness of patients with oesophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (The PERIOP-OG Trial): Study protocol for a randomised controlled trial.
    Tully R; Loughney L; Bolger J; Sorensen J; McAnena O; Collins CG; Carroll PA; Arumugasamy M; Murphy TJ; Robb WB;
    Trials; 2020 Jul; 21(1):638. PubMed ID: 32660526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.